Health & Veritas
Howard Forman and Harlan Krumholz, two Yale physician-professors, discuss the latest news and ideas in healthcare and seek out the truth amid the noise.
Produced with the Yale School of Management and the Yale School of Public Health. New episodes are available every Thursday.
Subscribe to Health & Veritas on Apple Podcasts, Spotify, YouTube, or your favorite podcast player.
Episodes
- PodcastEpisode 134Duration 32:25
Anna Reisman: Bringing the Humanities to Medicine
Howie and Harlan are joined by Anna Reisman, a physician and writer who leads Yale’s Program for Humanities in Medicine. They discuss the gaps in care she encountered when her developmentally disabled sister was diagnosed with cancer, and her work reviewing the “dude wall” of portraits at Yale Medical School. Harlan asks what we’ve gained from a new definition of long COVID; Howie provides an update on the spread of the H5N1 bird flu.
- PodcastEpisode 133Duration 38:10
Mitesh Rao: Democratizing Healthcare Data
Mitesh Rao, co-founder and CEO of OMNY Health, joins Howie and Harlan to discuss his entrepreneurial journey and how his company is creating a common layer of data connecting healthcare providers and researchers. Harlan reports on a study showing how many lives could be saved by improving quality of care; Howie reflects on the health consequences that have accompanied the legalization of cannabis.
- PodcastEpisode 132Duration 39:43
Live at the Yale Innovation Summit
A special episode recorded at the Yale Innovation Summit, which brings together entrepreneurs and investors in the arts, biotech, climate, health, and tech. Howie and Harlan are joined by Josh Geballe, managing director of Yale Ventures, which hosts the summit; Mary Ann Melnick, site head at Biolabs New Haven; and Lee Schwamm, chief digital health officer at Yale New Haven Health System.
- PodcastEpisode 131Duration 33:55
Chima Ndumele: Reinventing Medicaid
Howie and Harlan are joined by Chima Ndumele of the Yale School of Public Health to discuss his research on structural changes to Medicaid that could keep vulnerable populations healthier. Harlan reports on the remarkable abilities of Google's latest medicine-focused AI; Howie reflects on a study showing the impact of race-neutral measures of lung function.
- PodcastEpisode 130Duration 28:05
Ruth Katz: Crafting Landmark Legislation
Howie and Harlan are joined by Ruth Katz, executive director of the Aspen Institute’s Health, Medicine & Society Program and a former Capitol Hill staffer, to discuss her work on the Affordable Care Act and other major healthcare laws. Harlan reflects on a study showing that using different analytical approaches to the same data can lead to a wide range of conclusions; Howie reports on a wave of dangerous infections caused by stem cell treatments at clinics in Mexico.
- PodcastEpisode 129Duration 29:15
Greg Licholai: Breaking through the Innovation Bottleneck
Howie and Harlan are joined by Greg Licholai, a Yale SOM lecturer and biotech entrepreneur, to discuss his career and his work at the contract research organization ICON, which performs clinical trials for pharmaceutical companies. Harlan reports on new research illustrating the dangerous consequences of asking patients to share the costs of life-saving drugs; Howie provides the good news and the bad news from the annual Medicare Trustees Report.
- PodcastEpisode 128Duration 34:29
The Primary Care Crisis and Other News
Howie and Harlan discuss health and healthcare headlines. From flatlining telehealth to Walmart closing retail clinics to months-long waits for healthcare appointments, they try to untangle the challenges in delivering healthcare. Also considered, H5N1 bird flu increasing the risks of drinking unpasteurized milk, promising research on open-source moderation of misinformation on social media.
- PodcastEpisode 127Duration 31:08
Arthur Caplan: Medicine’s Toughest Ethical Questions
Howie and Harlan are joined by Arthur Caplan, Drs. William F. and Virginia Connolly Mitty Professor of Bioethics and founding head of the division of medical ethics at NYU Grossman School of Medicine, to discuss the ethical failings of the pharmaceutical industry and how a community-focused ethos prioritizing justice and protection of the vulnerable would have reshaped the COVID response. Harlan reports on developments in synthetic proteins. Howie recognizes World Malaria Day.
- PodcastEpisode 126Duration 37:59
Scott Berkowitz: Value-Based Care and Population Health
Howie and Harlan are joined by Scott Berkowitz ’03, cardiologist and chief population health officer at Johns Hopkins Medicine, to discuss the necessity of moving from fee-for-service to value-based care delivery to improve outcomes for all. Harlan highlights the dangers of misinformation about Ivermectin. Howie reports on the potential conflicts of interest created by device manufacturers’ payments to cardiologists.
- PodcastEpisode 125Duration 38:40
Atheendar Venkataramani: Opportunity, Hope, and Health
Howie and Harlan are joined by Atheendar Venkataramani, a physician, health economist, and director of the Perelman School of Medicine’s Opportunity for Health Lab, to discuss the powerful role of economic opportunity in population health outcomes. Harlan reports on two studies where treatments’ unexpected benefits leapt ahead of understanding why they work. Howie reflects on the business model of the pharma industry and the market reaction to anti-obesity drugs.